Organon & Co.
Pharmaceutical developer.
Based in NJ
AI Overview
With $95K in lobbying spend across 20 quarterly filings, Organon & Co is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $10K |
| 2022 | $20K |
| 2023 | $20K |
| 2024 | $25K |
| 2025 | $20K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Organon & Co. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
General issues of interest to pharmaceutical companies.
General Issues of interest to pharmaceutical companies
Medicare reimbursement of pharmaceuticals
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.